Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

NCT07168902 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: BL1107 Low dose
DRUG: BL1107 High dose
DRUG: Timolol maleate 0.5%

Sponsor

Bausch & Lomb Incorporated